Sept 26 (Reuters) - Pfizer Inc on Monday submitted an application to the U.S. Food and Drug Administration (FDA) requesting the authorization of an Omicron-specific COVID-19 vaccine booster for children aged 5 through 11 years. (Reporting by Leroy Leo in Bengaluru; Editing by Savio D'Souza)
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
28.24 USD | -0.69% | +1.67% | 161B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Pfizer seeks FDA nod for Omicron-retooled booster for kids aged 5-11 yrs